Inventor

LOCKHART DAVID J

US54 patents

⚠️ This page may combine multiple inventors who share the name “LOCKHART DAVID J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LOCKHART DAVID J

AFFYMETRIX INC

Expression monitoring by hybridization to high density nucleic acid arrays

Complexity management and analysis of genomic DNA

Expression monitoring by hybridization to high density oligonucleotide arrays

Nucleic acid probe libraries

Methods of identifying nucleic acid probes to quantify the expression of a target nucleic acid

Conformationally-restricted peptide probe libraries

Expression profiles in adult and fetal organs

Surface-bound, unimolecular, double-stranded DNA

Surface-bound, unimolecular, double-stranded DNA

Proportional amplification of nucleic acids

Nucleic acid analysis techniques

Expression monitoring by hybridization to high density oligonucleotide arrays

Computer-aided techniques for analyzing biological sequences

Exploiting genomics in the search for new drugs

Methods of genetic analysis using nucleic acid arrays

Methods for testing oligonucleotide arrays

Identification of molecular sequence signatures and methods involving the same

Methods for testing oligonucleotide arrays

Genotyping biallelic markers

Identification of molecular sequence signatures and methods involving the same

Exploiting genomics in the search for new drugs

Even length proportional amplification of nucleic acids

Identification of molecular sequence signatures and methods involving the same

Methods for testing oligonucleotide arrays

Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA

Identification of molecular sequence signatures and methods involving the same

AMICUS THERAPEUTICS INC

Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones

Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones

Methods for treatment of fabry disease

Methods for treatment of Fabry disease

Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones

Methods for treatment of Fabry disease

Methods for treatment of Fabry disease

Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones

AMBIT BIOSCIENCES CORP

Isoxazolyl urea derivatives as kinase modulators

Uncoupling of DNA insert propagation and expression of protein for phage display

Substituted 3-carboxamido isoxazoles as kinase modulators

Uncoupling of DNA insert propagation and expression of protein for phage display

RECODE THERAPEUTICS INC

Lipid nanoparticle compositions and uses thereof

Lipid nanoparticle compositions and uses thereof

Lipid nanoparticle compositions and uses thereof

Polynucleotide compositions, related formulations, and methods of use thereof

LOCKHART DAVID J

Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones

Treatment of gaucher disease with specific pharmacological chaperones and monitoring treatment using surrogate markers

Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA

TRANSCRIPTX INC

Treatment of primary ciliary dyskinesia with synthetic messenger RNA

Treatment of primary ciliary dyskinesia with synthetic messenger RNA

Treatment of primary ciliary dyskinesia with synthetic messenger RNA

UNIV CALIFORNIA

Methods of using chemical libraries to search for new kinase inhibitors

LOCKHART DANIEL J

Multiple compartment dosing model